TerrAscend (TSNDF) EBITDA (2021 - 2026)
TerrAscend (TSNDF) reported EBITDA of -$7.7 million for Q1 2026, up 37.15% year-over-year from -$5.6 million in Q1 2025, and down 325.47% quarter-over-quarter from $3.4 million in Q4 2025.
TerrAscend (TSNDF) EBITDA (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of EBITDA data on file, last reported at -$7.7 million in Q1 2026.
- EBITDA for Q1 2026 came in at -$7.7 million, up 37.15% year-over-year; the trailing twelve-month figure through Mar 2026 was -$77.8 million (down 12.34% YoY), and the FY2025 annual result was -$82.4 million, down 15.25% from the prior year.
- EBITDA fell to -$7.7 million in Q1 2026 per TSNDF's latest filing, from $3.4 million in the prior quarter.
- Over five years, EBITDA peaked at $13.9 million in Q2 2022 and troughed at -$308.2 million in Q3 2022.
- A 5-year average of -$33.0 million and a median of -$13.9 million in 2023 frame the typical range for EBITDA.
- The sharpest annual moves came in 2022 and 2025: EBITDA tumbled 82513.64% in 2022, then soared 112.32% in 2025.
- A 5-year view of EBITDA shows it stood at -$12.1 million in 2022, then tumbled by 243.13% to -$41.6 million in 2023, then soared by 33.37% to -$27.7 million in 2024, then soared by 112.32% to $3.4 million in 2025, then slumped by 325.47% to -$7.7 million in 2026.
- Business Quant data shows TSNDF's EBITDA at -$7.7 million in Q1 2026, $3.4 million in Q4 2025, and -$24.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 652.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 833.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 325.80 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -681,231.97 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 185.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 307.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -67.29 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 81.33 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -98.81 Mn |
| 10 | TerrAscend | - | - | 34.60 Mn | -7.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.70 Mn |
| Dec 31, 2025 | 3.42 Mn |
| Sep 30, 2025 | -24.56 Mn |
| Jun 30, 2025 | -48.96 Mn |
| Mar 31, 2025 | -12.26 Mn |
| Dec 31, 2024 | -27.74 Mn |
| Sep 30, 2024 | -23.29 Mn |
| Jun 30, 2024 | -5.98 Mn |
| Mar 31, 2024 | -14.45 Mn |
| Dec 31, 2023 | -41.63 Mn |
| Sep 30, 2023 | -8.39 Mn |
| Jun 30, 2023 | -13.88 Mn |
| Mar 31, 2023 | -23.12 Mn |
| Dec 31, 2022 | -12.13 Mn |
| Sep 30, 2022 | -308.23 Mn |
| Jun 30, 2022 | 13.88 Mn |
| Mar 31, 2022 | -5.78 Mn |
| Dec 31, 2021 | 8.62 Mn |
| Sep 30, 2021 | 374,000.00 |
| Jun 30, 2021 | 14.05 Mn |